glp 1 and the brain Frontiers A sympathetic brake on gut

When you stop a GLP-1 medication, the drug clears your system based on its half-life

GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: a population-based study

And natural options should never replace medications prescribed by your healthcare provider

Techniques such as mindfulness, adequate sleep, and relaxation exercises support overall digestive health

Its a small trial with only 1-year follow up and lacking hard endpoints such as hospitalization or cardiovascular deaths, but the results for symptomatic relief and gain in physical activity are certainly very encouraging

Collaborations and pharma partnerships for obesity drug development are accelerating innovation, combining expertise to bring next-generation therapies to market faster